CONSOLIDATED FINANCIAL STATEMENTS >
DIRECTORS’ REPORT
12
| 2013 ANNUAL REPORT | PRYSMIAN GROUP
FINANCIAL HIGHLIGHTS
MAIN FINANCIAL AND OPERATING DATA (*)
(in millions of Euro)
2013
2012(***)
Change %
2011(**)
Sales
7,273
7,848
-7.3%
7,583
EBITDA
(1)
562
546
2.9%
269
Adjusted EBITDA
(2)
612
647
-5.5%
568
Operating income
360
362
-0.8%
19
Adjusted operating income
(3)
457
483
-5.4%
426
Profit/(loss) before taxes
222
242
-8.4%
(101)
Net profit/(loss) for the year
154
169
-8.6%
(145)
(in millions of Euro)
31 December 2013 31 December 2012(***)
Change
31 December 2011
Net capital employed
2,337
2,421
(84)
2,436
Employee benefit obligations
308
344
(36)
268
Equity
1,195
1,159
36
1,104
of which attributable to non-controlling interests
48
47
1
62
Net financial position
834
918
(84)
1,064
(in millions of Euro)
2013
2012(***)
Change %
2011(**)
Investments
(4)
144
152
-5.3%
159
Employees (at period end)
19,374
19,896
-2.6%
21,547
Earnings/(loss) per share
- basic
0.71
0.79
(0.65)
- diluted
0.71
0.78
(0.65)
Patents(****)
5,731
5,644
5,288
Number of plants
91
91
97
Percentage of plants certified ISO 14001
86%
82%
80%
Percentage of plants certified OHSAS 18001
49%
42%
40%
(1)
EBITDA is defined as earnings/(loss) for the year, before the fair value change in metal derivatives and in other fair value items, amortisation,
depreciation, and impairment, finance costs and income, the share of net profit/(loss) of associates, dividends from other companies and taxes.
(2)
Adjusted EBITDA is defined as EBITDA before non-recurring income/(expenses).
(3)
Adjusted operating income is defined as operating income before non-recurring income/(expenses) and the fair value change in metal derivatives and
in other fair value items.
(4)
Investments refer to increases in Property, plant and equipment and Intangible assets.
(*) All percentages contained in this report have been calculated with reference to amounts expressed in thousands of Euro.
(**) Includes the Draka Group’s results for the period 1 March – 31 December 2011.
(***) The previously published figures have been amended. Further details can be found in Section C. Restatement of comparative figures at 31 December
2012 in the Explanatory Notes to the Consolidated Financial Statements.
(****) The figures report the total number of patents, comprising patents granted plus patent applications pending worldwide.
